ISRCTN54702843已完成未知
Septal closure of patent foramen ovale: does it prevent migraine?
St Jude Medical Inc (Belgium)0 个研究点目标入组 50 人开始时间: 2007年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Migraine with aura
- •2. Migraine history of at least one year:
- •a. at least two migraine attacks/month
- •b. at least one migraine attack with aura
- •3. Failure or intolerance to two classes prophylactic migraine medication
- •4. Aged 18 to 50 years
- •5. Right to left shunt suitable for closure
排除标准
- •1. History of 15 or more headache days per month
- •2. Taking preventive medication for other conditions other than migraine
- •3. Eight or more non-migraine headache days/month
- •4. Overuse of acute headache medication (use on ten or more days/month)
- •5. Severe central nervous system disease
- •6. Previous surgical or device closure of Patent Foramen Ovale (PFO)/Atrial Septal Defect (ASD)
- •7. Atrial heart valve
- •8. Pacemaker or Implantable Cardioverter Defibrillator (ICD) implanted within past three months
- •9. History of atrial fibrillation
- •10. Undergoing dialysis
- •11. New York Heart Association (NYHA) class three or four cardiac failure
- •12. Pregnant
- •13. Anticoagulation
研究者
相似试验
已完成
不适用
Transcatheter closure of patent foramen ovale in patients with migraineMigraineJPRN-UMIN000017216Okayama University Hospital30
进行中（未招募）
1 期
Comparison of three different strategies of preventing a second stroke in patients with a small hole in the wall dividing the right side of the heart from the left side:-two different forms of blood thinning medication: - long-time antiplatelet therapy - long-time anticoagulant therapyor - closure of the hole by implanting a small metal device using a catheter, followed by long-time antiplatelet therapyThe study compares different strategies for secondary stroke (or retinal ischaemia) prevention in patients with patent foramen ovale.The three treatment arms comprise: 1. Endovascular patent foramen ovale closure followed by long-term antiplatelet therapy 2. long-term anticoagulant therapy 3. long-term antiplatelet therapyMedDRA version: 19.0Level: LLTClassification code 10036654Term: PreventionSystem Organ Class: 100000004865MedDRA version: 19.0Level: LLTClassification code 10016982Term: Foramen ovale patentSystem Organ Class: 100000004850MedDRA version: 19.0Level: LLTClassification code 10042244Term: StrokeSystem Organ Class: 100000004852EUCTR2011-000110-19-DEAssistance Publique – Hôpitaux de Paris (AP-HP)900
已完成
不适用
PREMIUM Migraine TrialMigraine HeadachesPatent Foramen OvaleNCT00355056Abbott Medical Devices230
撤回
不适用
Close Obstructive Sleep Apnea (OSA) TrialObstructive Sleep ApneaPatent Foramen OvaleNCT06113562University of Miami60
终止
不适用
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCIPFOStrokeTIAPatent Foramen OvaleNCT01018355Hillerod Hospital, Denmark3,000